These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21235816)

  • 1. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India.
    Solomon SS; Srikrishnan AK; Celentano DD; Johnson SC; Vasudevan CK; Murugavel KG; Anand S; Kumar MS; Solomon S; Mehta SH
    BMC Public Health; 2011 Jan; 11():39. PubMed ID: 21235816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV prevalence and related risk behaviours among female partners of male injecting drugs users in Iran: results of a bio-behavioural survey, 2010.
    Alipour A; Haghdoost AA; Sajadi L; Zolala F
    Sex Transm Infect; 2013 Nov; 89 Suppl 3(Suppl 3):iii41-4. PubMed ID: 24064986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS; Srikrishnan AK; Mehta SH; Vasudevan CK; Murugavel KG; Thamburaj E; Anand S; Kumar MS; Latkin C; Solomon S; Celentano DD
    J Acquir Immune Defic Syndr; 2008 Nov; 49(3):327-32. PubMed ID: 18845962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV sexual risk behaviors among injection drug users in Shanghai.
    Zhao M; Du J; Lu GH; Wang QY; Xu H; Zhu M; McCoy CB
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S43-7. PubMed ID: 16769445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
    Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
    BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of an HIV prevention intervention among people who inject drugs in the states of Manipur and Nagaland, India.
    Goswami P; Medhi GK; Armstrong G; Setia MS; Mathew S; Thongamba G; Ramakrishnan L; George B; Singh RK; Paranjape RS; Mahanta J
    Int J Drug Policy; 2014 Sep; 25(5):853-64. PubMed ID: 24925819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India.
    Panda S; Kumar MS; Lokabiraman S; Jayashree K; Satagopan MC; Solomon S; Rao UA; Rangaiyan G; Flessenkaemper S; Grosskurth H; Gupte MD
    J Acquir Immune Defic Syndr; 2005 May; 39(1):9-15. PubMed ID: 15851908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV risk behaviors of male injecting drug users and associated non-condom use with regular female sexual partners in north-east India.
    Mishra RK; Ganju D; Ramesh S; Lalmuanpuii M; Biangtung L; Humtsoe C; Saggurti N
    Harm Reduct J; 2014 Feb; 11():5. PubMed ID: 24520914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
    Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
    Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L; Assanangkornchai S; Duo L; McNeil E; Li J
    PLoS One; 2014; 9(9):e106899. PubMed ID: 25203256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
    Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
    Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
    AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
    Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
    Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
    Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
    Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV risk behaviours among injecting drug users in Northeast India following scale-up of a targeted HIV prevention programme.
    Armstrong G; Humtsoe C; Kermode M
    BMC Public Health; 2011 Dec; 11 Suppl 6(Suppl 6):S9. PubMed ID: 22375900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
    Deryabina AP; Patnaik P; El-Sadr WM
    Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk behaviours and seroprevalence to HIV, HBV and HCV in patients of the AIDS information and prevention center in Valencia, Spain].
    Alfonso Gil R; Hurtado Navarro I; Espacio Casanovas A; Santos Rubio G; Tomás Dols S
    Gac Sanit; 1999; 13(1):16-21. PubMed ID: 10217673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.